A Comparison of PRP Treatment to the IA vs. IA and EA Environments in Patients Diagnosed With Hip Osteoarthritis
Status unconfirmed · Phase 1
Conditions studied: Osteoarthritis, Hip, Osteoarthritis, Degeneration
In brief
The purpose of this study is to evaluate the efficacy of one leukocyte-poor platelet-rich plasma (LP-PRP) injection to the intra-articular (IA) space in comparison to one LP-PRP injection to the IA space with an additional injection into the surrounding extra-articular (EA) structures for the treatment of hip OA (Kellgren Lawrence Grades 1-3). Our hypothesis is that patients receiving both IA and EA LP-PRP injections will have equivalent improvements on HOOS JR and VAS scores over a 12-month period compared to those in the active comparator group (IA LP-PRP injection).
Key facts
- Study ID
- NCT04241354
- Run by
- Regenerative Orthopedics and Sports Medicine
- People needed
- 84
- Starts
- 2021-08-25
- Expected to finish
- 2022-08-25
- Last updated by the study team
- 2021-09-09
Who can join
Age: 30 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Regenerative Orthopedics and Sports Medicine — North Bethesda, Maryland, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.